|
PPP1R9A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.882120E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.200400E-03 |
| Normal-vs-Stage2 |
1.413160E-01 |
| Normal-vs-Stage3 |
4.635800E-02 |
| Normal-vs-Stage4 |
8.842400E-03 |
| Stage1-vs-Stage2 |
6.128600E-01 |
| Stage1-vs-Stage3 |
6.151000E-01 |
| Stage1-vs-Stage4 |
6.301800E-01 |
| Stage2-vs-Stage3 |
9.004000E-01 |
| Stage2-vs-Stage4 |
3.933800E-01 |
| Stage3-vs-Stage4 |
4.114800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.612500E-04 |
| Normal-vs-AfricanAmerican |
3.528100E-02 |
| Normal-vs-Asian |
7.418400E-01 |
| Caucasian-vs-AfricanAmerican |
4.169200E-01 |
| Caucasian-vs-Asian |
9.176100E-03 |
| AfricanAmerican-vs-Asian |
5.848400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.868290E-02 |
| Normal-vs-Female |
2.196300E-03 |
| Male-vs-Female |
8.031000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.256900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.442000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.956200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.536200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.023800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.133000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.319700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.817200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.461000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.485600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.350760E-01 |
| Classical-VS-Follicular |
6.26660000002666E-07 |
| Classical-VS-Other |
5.387800E-01 |
| Classical-VS-Normal |
1.76677000000014E-05 |
| Tall-VS-Follicular |
4.586000E-02 |
| Tall-VS-Other |
9.945200E-01 |
| Tall-VS-Normal |
9.909800E-02 |
| Follicular-VS-Other |
2.850000E-01 |
| Follicular-VS-Normal |
4.382400E-01 |
| Other-VS-Normal |
3.259800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.315420E-01 |
| Normal-vs-N1 |
4.200000E-02 |
| N0-vs-N1 |
3.418400E-01 |
|
|
